Related references
Note: Only part of the references are listed.Low nigrostriatal reserve for motor parkinsonism in nonhuman primates
Samer D. Tabbal et al.
EXPERIMENTAL NEUROLOGY (2012)
No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease
LinLin Tian et al.
PLOS ONE (2012)
Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's
Jacqueline A. Gleave et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Spatial Remapping of Cortico-striatal Connectivity in Parkinson's Disease
Rick C. Helmich et al.
CEREBRAL CORTEX (2010)
18F-FECNT: Validation as PET dopamine transporter ligand in parkinsonism
Gunasingh Masilamoni et al.
EXPERIMENTAL NEUROLOGY (2010)
Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease
Chris C. Tang et al.
JOURNAL OF NEUROSCIENCE (2010)
Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease
W. R. Wayne Martin et al.
ANNALS OF NEUROLOGY (2008)
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease
Ming-Kai Chen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Quantitative [123I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease
D. Alvarez-Fischer et al.
NEUROIMAGE (2007)
Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid
Morvarid Karimi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine
S. D. Tabbal et al.
NEUROSCIENCE (2006)
Registration of [18F]FDG microPET and small-animal MRI
DJ Rowland et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
The role of radiotracer imaging in Parkinson disease
B Ravina et al.
NEUROLOGY (2005)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease
DJ Brooks et al.
EXPERIMENTAL NEUROLOGY (2003)
Endogenous dopamine release after pharmacological challenges in Parkinson's disease
P Piccini et al.
ANNALS OF NEUROLOGY (2003)
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease
W Meissner et al.
MOLECULAR NEUROBIOLOGY (2003)
Novel observations with FDOPA-PET imaging after early nigrostriatal damage
RE Yee et al.
MOVEMENT DISORDERS (2001)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
